Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meridian Bioscience develops and commercializes molecular and immunological diagnostic products as well as life science reagents. Its portfolio includes FDA-cleared assays such as Premier HpSA FLEX for H. pylori diagnosis and Curian Shiga Toxin assay. In June 2024, it launched its first lyophilized NGS library prep kit. The company supplies critical raw materials to diagnostics manufacturers globally and serves healthcare providers in over seventy countries with solutions spanning from discovery to diagnosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meridian Bioscience.